4TYD
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Summary for 4TYD
Entry DOI | 10.2210/pdb4tyd/pdb |
Descriptor | NS3 protease, ZINC ION, (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide, ... (5 entities in total) |
Functional Keywords | structure-based design, hcv ns3/4a serine protease, azetidine inhibitors, proteros biostructures gmbh, hydrolase |
Biological source | Hepatitis C virus (isolate 1) |
Total number of polymer chains | 12 |
Total formula weight | 267727.95 |
Authors | Parsy, C. (deposition date: 2014-07-08, release date: 2014-09-10, Last modification date: 2018-04-25) |
Primary citation | Parsy, C.,Alexandre, F.R.,Brandt, G.,Caillet, C.,Cappelle, S.,Chaves, D.,Convard, T.,Derock, M.,Gloux, D.,Griffon, Y.,Lallos, L.,Leroy, F.,Liuzzi, M.,Loi, A.G.,Moulat, L.,Musiu, C.,Rahali, H.,Roques, V.,Seifer, M.,Standring, D.,Surleraux, D. Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease. Bioorg.Med.Chem.Lett., 24:4444-4449, 2014 Cited by PubMed: 25155387DOI: 10.1016/j.bmcl.2014.08.002 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.84 Å) |
Structure validation
Download full validation report